Press Releases

BELVIDERE, NJ, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, better-for-you, sustainable produce and products, and Square Roots, an agricultural innovation company founded on the belief that controlled-environment agriculture could empower a new generation of farmers while using technology to produce fresher, locally grown food with enhanced taste and nutritional attributes, today announced a strategic product development partnership to develop a new generation of clean-label, functional ready-to-drink ("RTD") beverages. The collaboration

Deployment of Additional OCTs Marks Major Milestone Toward SDA’s Proliferated Warfighter Space Architecture Skyloom Global, LLC, an IonQ (NYSE:IONQ) company specializing in the development of space-based optical technology for secure, high-performance communications, today announced that dozens of additional optical communication terminals (OCTs) have been successfully deployed on orbit. The OCTs were aboard York Space Systems satellites supporting the Space Development Agency’s (SDA) Proliferated Warfighter Space Architecture (PWSA). The satellites equipped with the company’s optical technology were launched July 16, 2026, aboard a SpaceX Falcon 9 rocket from Vandenberg Space Force Bas

TOKYO and CAMBRIDGE, Mass., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (NASDAQ:BIIB), announced today that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cognitive impairment (MCI) or mild dementia due to AD, collectively referred to as early AD. MCI due to AD is the earliest symptomatic stage of AD and can appear with subtle symptoms such as forgetfulness, confusion, or feeling at a loss for words.1 LEQEMBI IQLIK is administered via an autoinjector, introducing a convenient alternative to intravenous (IV) dosing from the start o

Crossing the finish line within the 30-hour cutoff, 387 runners earned belt buckles at the legendary Life Time Leadville Trail 100 Run presented by La SportivaLEADVILLE, Colo., Aug. 24, 2026 /PRNewswire/ -- McKendree Hickory of Steamboat Springs, Colorado, delivered a breakthrough performance in her first Life Time Leadville Trail 100 Run presented by La Sportiva, winning in 19:39:12. After placing fifth at the Leadville Marathon earlier this summer, Hickory returned to Leadville for her first attempt at the 100-mile distance, steadily working her way through the field before taking the lead late in the race. Previous Leadville Trail 100 champion Jacquie Mannhard finished second in 20:28:37,

U.S. publication of the patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration with Neurothera Labs Inc. as the FDA  introduces a dedicated regulatory structure for psychedelic drug development, including MDMA Vancouver, Canada, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), a clinical-stage biopharmaceutical  company   advancing non-hallucinogenic, psychedelic-derived neuroplastogens  for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders, including AUD,  today announced  an advancement of its IP portfolio with the publication in the United States of its pat

Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Carrier Connect Data Solutions Inc. (TSXV:CCDS) (OTCQB:CCDSF) (WKN: A40XB1) (the "Company" or "Carrier"), a data center company on a mission to roll up Tier II/III data centers internationally that specialize in delivering co-location is pleased to announce the appointment of Mr. Aleem Nathwani to lead the Company's Corporate Development efforts, effective immediately.Mr. Nathwani brings more than 20 years of private and public market experience, with a significant focus on the data center, cloud and technology sectors. Throughout his career, he has been involved with early-stage and growth-stage companies and has held a numbe

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –BOULDER, Colo., Aug. 24, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today announced that the CIRRUS-HCM abstract was selected for a late-breaking science presentation at the European Society of Cardiology (ESC) Congress, taking place August 28-31 in Munich, Germany. EDG-7500 is a novel, oral, selective cardiac sarcomere modulator designed to slow early contraction and improve cardiac relaxation in symptomatic HCM while

LEQEMBI IQLIK is the first-of-its-kind anti-amyloid treatment worldwide offering at-home dosing for initiation and maintenance (approved in the U.S.)TOKYO and CAMBRIDGE, Mass., Aug. 24, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (NASDAQ:BIIB), announced today that once weekly lecanemab‑irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer's disease (AD) in adults with mild cognitive impairment (MCI) or mild dementia due to AD, collectively referred to as early AD. MCI due to AD is the earliest symptomatic stage of AD and can appear with subtle symptoms such as forgetfulness, confusion, or feeling at a loss f

– 17 abstracts and presentations planned at SSIEM Symposium –– Real-world evidence demonstrates significant diet liberalization achieved with Sephience while maintaining target blood Phe levels – – Continued evidence of meaningful benefit across all patient subgroups – WARREN, N.J., Aug. 24, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) today announced that multiple Sephience™ (sepiapterin) scientific data presentations will be featured at the 2026 Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium, taking place in Helsinki, Finland, from Aug. 25-28. The presentations include new data from clinical trials and real-world evidence which reinforce the clin

Current Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.Dr. Madaus has served in multiple CEO roles in the diagnostics and life science tools industry and joined the Azenta Board in 2024 – making him the ideal individual to lead the Company during this transition. He is a Senior O

MIAMI, Aug. 24, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, is pleased to announce a new strategic alliance with renowned electronics manufacturer HTC of Taiwan. The alliance is centered on the US commercialization of the VIVE Eagle smart eyewear line, which Innovative Eyewear plans to make available on its flagship Lucyd.co smart eyewear web store. The glasses will be offered with Innovative's US-based prescription lens fulfillment, and Lucyd.co will be offering prescriptions for US customers at launch. The

Relative to prior 2026 guidance issued with Q4 2025 earnings release, Kimbell expects:Record daily production, which at its midpoint for Q3 2026 and Q4 2026 guidance is a 10% and 15% increase, respectively, over the midpoint of prior 2026 guidanceIncrease in oil production mix with Permian leading all categories including revenue, production, DUCs, permits and PUDsReduction in expected cash G&A per Boe, reflecting positive operating leverageFORT WORTH, Texas, Aug. 24, 2026 /PRNewswire/ -- Kimbell Royalty Partners, LP (NYSE:KRP) ("Kimbell" or the "Company"), a leading owner of oil and gas mineral and royalty interests in over 17 million gross acres in 28 states, today announced updated guidan

Increase driven by the fair-value recognition of 9BIT tokens received under the Company's cooperation agreement with the 9BIT Foundation as the9bit continued to expand AI capabilities, community engagement and commercial partnershipsSHANGHAI, Aug. 24, 2026 /PRNewswire/ -- The9 Limited (NASDAQ:NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today reported its unaudited financial results for the three months ended June 30, 2026. Second Quarter 2026 HighlightsStrong sequential growth: Net income for the quarter was US$32 million, an increase of more than 39% from the previous quarter.Record profitability: Net income for the first half of 2026 reached US$55 million, rep

Initial pool of more than 80 robots is expected to support operations as the company develops a multi-brand marketplace beginning with Faraday Future.LOS ANGELES, Aug. 24, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ:AIXC) today announced that RoboShare, its robot-sharing marketplace operated through its subsidiary, has secured additional short-term and longer-term service orders following its first paid commercial order. An initial pool of more than 80 robots will provide the starting supply for the company's 90-day plan to evaluate demand, utilization, service delivery, and unit economics through real customer orders. Since announcing our strategic transformation, we have seen a s

Abacus Global Management, Inc. (NYSE:ABX) ("Abacus" or the "Company"), an alternative asset manager focused on longevity-based assets with data-driven wealth and technology solutions, today announced the publication of a letter from Chief Investment Officer Elena Plesco addressing recent investor questions on interest rate sensitivity and the Company's valuation approach. Following investor calls held after the Company's second quarter 2026 earnings release, Abacus received frequent questions on two topics: how movements in prevailing discount rates affect the Company's business, and an update to the methodology used to value policies held on its balance sheet. The letter, titled "Valuati

ThinkEquity LLC, One of Wall Street’s Leading Investment Banks, Becomes Financial Advisor to the Company Hawkeye Systems, Inc. (OTC:HWKE) ("Hawkeye" or the "Company") today announced that the Company's name has been changed from Hawkeye Systems, Inc. to Hawkeye Digital, Inc. The new name, along with a new logo, reflects Hawkeye's transformation into a private equity and merchant banking platform focused on digital assets and advanced technology. Alongside the rebrand, Hawkeye has relocated its headquarters to Miami Beach, Florida. The Company is currently hiring merchant bankers to expand its advisory and capital markets team as it builds out the platform. Hawkeye operates two complem

AEG and Archer announce exclusive multi-year partnership and collaboration to develop a vertiport at L.A. LIVE, AEG’s four-million-square-foot sports and entertainment district in downtown Los Angeles, with Archer as the district’s exclusive air taxi provider. As the first vertiport announced in downtown Los Angeles, the site would add an iconic location to Archer's planned Los Angeles air taxi network, giving fans, artists, and visitors the ability to take Archer’s air taxi service to and from L.A. LIVE – AEG’s downtown Los Angeles sports and entertainment district adjacent to Crypto.com Arena. The collaboration supports Archer's preparations for the LA28 Games as the Official Air T

Partnership strengthens Papa Johns presence in Mexico and reinforces its global commitment to delivering Better Ingredients. Better Pizza. Papa Johns today announced that KM Capital has joined the Papa Johns brand as the new franchise partner in Mexico. KM Capital will assume leadership of 44 existing franchised restaurants across the country, bringing a renewed focus on commercial growth, operational excellence, innovation and delivering on the brand’s Better Ingredients. Better Pizza. Promise. Mexico is a priority growth market for Papa Johns International and an important part of the company's long-term expansion strategy. As the world's third-largest pizza market and one of the larg

McGraw Hill, Inc. (NYSE:MH) today announced the following events: Philip Moyer, President, Chief Executive Officer and member of the Board of Directors of McGraw Hill, Inc., and Dr. Jason Yeatman, Ph.D., associate professor at Stanford University Graduate School of Education and Department of Psychology, will participate in an investor call hosted by Shlomo Rosenbaum, Managing Director Business & Information Services at Stifel. The call will take place on Wednesday, September 2, 2026, at 2:00 PM ET. The discussion will focus on the increasing emphasis on Science of Reading-based literacy standards in the United States and McGraw Hill’s recent exclusive integration of ROAR (Rapid Online

Designation follows encouraging Phase 1 activity across multiple tumor types including 2L+ KRAS G12X pancreatic cancer Three potentially registration-enabling trials planned across pancreatic and lung cancers Additional Phase 1 monotherapy and combination data expected in H1 2027 SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to ERAS-0015 for the treatment of patients with metastatic panc